Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

BioNTech SE ADR buy Traumtanz

Start price
€143.15
26.12.22 / 50%
Target price
-
01.03.24
Performance (%)
-32.11%
End price
€97.18
15.05.23
Summary
This prediction ended on 15.05.23 with a price of €97.18. Massive losses of -32.11% were the result for the BUY prediction by Traumtanz. Traumtanz has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
BioNTech SE ADR 7.896% 7.896% 243.124%
iShares Core DAX® 4.015% 2.971% 16.492%
iShares Nasdaq 100 2.755% 0.503% 40.029%
iShares Nikkei 225® -0.826% -5.057% 14.566%
iShares S&P 500 2.330% 0.720% 30.194%

According to Traumtanz what are the pros and cons of BioNTech SE ADR for the foreseeable future?

Pros
Very valuable balance sheet
Could be worthwhile Investment >10% per year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Rising EBIT margin expected
Undervalued
Very high dividend yield expected
Top Rating
Standard Investments for future growth
ROE higher than 15% per year
Normal challenges to pay loans and raise capital
Capable Management
Good culture
Leading role in innovation
Some uniques
Very differentiated customer and product portfolio
Growths faster than the competition
Small Risks for its business
Market Leader or Top 3
Small cyclical dependencies
Future proof or reliable business model
Very positive Cash Flow expected
Stable Large shareholder and/or long term investor
Well known brand
Sustainability is very important
Cons

Comments by Traumtanz for this prediction

In the thread Biontech SE diskutieren

Buy BioNTech SE ADR

In the thread Trading Biontech SE
Prediction Buy
Perf. (%) -32.11%
Target price
Change
Ends at 01.03.24

Buy beendet

Stopped prediction by Traumtanz for BioNTech SE ADR

buy
BioNTech SE ADR

Start price
Target price
Perf. (%)
€93.90
18.12.23
€95.00
18.12.24
2.19%
28.12.23

Very valuable balance sheet
Could be worthwhile Investment >10% per year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
buy
BioNTech SE ADR

Start price
Target price
Perf. (%)
€97.18
15.05.23
€100.00
15.05.24
1.34%
01.06.23

Very valuable balance sheet
Could be worthwhile Investment >10% per year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
buy
BioNTech SE ADR

Start price
Target price
Perf. (%)
€165.75
13.12.22
€170.00
13.12.23
5.61%
15.12.22

Very valuable balance sheet
Could be worthwhile Investment >10% per year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
buy
BioNTech SE ADR

Start price
Target price
Perf. (%)
€155.10
04.11.22
€160.00
04.11.23
3.51%
09.12.22

Very valuable balance sheet
Could be worthwhile Investment >10% per year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
buy
BioNTech SE ADR

Start price
Target price
Perf. (%)
€146.65
17.09.22
€150.00
17.09.23
5.39%
04.11.22

Very valuable balance sheet
Could be worthwhile Investment >10% per year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
buy
BioNTech SE ADR

Start price
Target price
Perf. (%)
€162.65
30.03.22
€180.00
30.03.23
6.06%
04.08.22

Very valuable balance sheet
Could be worthwhile Investment >10% per year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
buy
BioNTech SE ADR

Start price
Target price
Perf. (%)
€88.51
21.12.20
€80.00
-2.06%
21.12.20

Very valuable balance sheet
Could be worthwhile Investment >10% per year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
BioNTech SE ADR

Start price
Target price
Perf. (%)
€84.99
18.12.20
€80.00
4.14%
21.12.20

Very valuable balance sheet
Could be worthwhile Investment >10% per year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
buy
BioNTech SE ADR

Start price
Target price
Perf. (%)
€87.01
18.12.20
€80.00
-2.32%
18.12.20

Very valuable balance sheet
Could be worthwhile Investment >10% per year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
BioNTech SE ADR

Start price
Target price
Perf. (%)
€85.50
17.12.20
€80.00
1.77%
18.12.20

Very valuable balance sheet
Could be worthwhile Investment >10% per year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
buy
BioNTech SE ADR

Start price
Target price
Perf. (%)
€107.02
11.12.20
€110.00
-20.11%
17.12.20

Very valuable balance sheet
Could be worthwhile Investment >10% per year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
buy
BioNTech SE ADR

Start price
Target price
Perf. (%)
€103.62
07.12.20
€105.00
3.28%
11.12.20

Very valuable balance sheet
Could be worthwhile Investment >10% per year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
buy
BioNTech SE ADR

Start price
Target price
Perf. (%)
€100.02
05.12.20
€102.00
3.60%
07.12.20

Very valuable balance sheet
Could be worthwhile Investment >10% per year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
buy
BioNTech SE ADR

Start price
Target price
Perf. (%)
€96.00
09.11.20
€105.00
2.08%
01.12.20

Very valuable balance sheet
Could be worthwhile Investment >10% per year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected